{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:17:36Z","timestamp":1700525856225},"reference-count":17,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T00:00:00Z","timestamp":1384387200000},"content-version":"vor","delay-in-days":4304,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microbiology and Immunology"],"published-print":{"date-parts":[[2002,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Two surface\u2010active compounds, egg lecithin and polysorbate 80, usually used as the deactivators of various preservatives were tested whether they also counteract either or all of the three major topical antifungal drugs, bifonazole (BFZ), lanoconazole (LCZ) and terbinafine (TBF). Both egg lecithin and polysorbate 80, when added to culture media up to final concentrations of 1.0 and 0.7%, respectively, antagonized the anti\u2010dermatophytic activity of the three drugs in a concentration\u2010dependent manner. A greater extent of antagonistic action was exerted when the two deactivators combined at their maximal levels tested were added; MIC's of BFZ were increased more than 30\u2010fold and those of LCZ and TBF more than 200\u2010fold compared with the values obtained in the absence of the deactivators. Using the agar medium supplemented with the combined deactivators, culture studies were carried out with skin tissues specimens taken from guinea pigs whose feet were infected with dermatophytes and subsequently treated with 1% topical preparations of the three antifungal drugs. The experimental data from this animal study demonstrated that the combined deactivators\u2010supplemented medium yielded increased numbers of fungi compared with the basal medium. It looks, therefore, likely that the fungal recovery on the former medium more correctly reflects to actual fungal burden in the infected lesions than the latter. All these results suggest that the combined deactivators\u2010supplemented medium is more useful for mycological evaluation of therapeutic efficacy of imidazole and allylamine drugs against dermatophytoses in both preclinical and clinical studies.<\/jats:p>","DOI":"10.1111\/j.1348-0421.2002.tb02662.x","type":"journal-article","created":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T15:35:10Z","timestamp":1384443310000},"page":"83-88","source":"Crossref","is-referenced-by-count":13,"title":["Development of a New Medium Useful for the Recovery of Dermatophytes from Clinical Specimens by Minimizing the Carryover Effect of Antifungal Agents"],"prefix":"10.1111","volume":"46","author":[{"given":"Takuji","family":"Nakashima","sequence":"first","affiliation":[{"name":"Pharmaceutical R&amp;D Laboratories POLA Chemical Industries, Inc.  Yokohama Kanagawa 244\u20100812 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Nozawa","sequence":"additional","affiliation":[{"name":"Pharmaceutical R&amp;D Laboratories POLA Chemical Industries, Inc.  Yokohama Kanagawa 244\u20100812 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Ito","sequence":"additional","affiliation":[{"name":"Pharmaceutical R&amp;D Laboratories POLA Chemical Industries, Inc.  Yokohama Kanagawa 244\u20100812 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Majima","sequence":"additional","affiliation":[{"name":"Pharmaceutical R&amp;D Laboratories POLA Chemical Industries, Inc.  Yokohama Kanagawa 244\u20100812 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyo","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Teikyo University Institute of Medical Mycology Teikyo University  Hachioji Tokyo 192\u20100352 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,11,14]]},"reference":[{"key":"e_1_2_2_2_1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/aem.32.1.80-84.1976","article-title":"Influence of possible disinfectant transfer on Staphylococcus aureus plate counts after agar contact sampling","volume":"32","author":"Brummer B.","year":"1976","journal-title":"Appl. Environ. Microbiol."},{"key":"e_1_2_2_3_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.118.3062.274"},{"key":"e_1_2_2_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.2.314"},{"key":"e_1_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.3314\/jjmm.33.321"},{"key":"e_1_2_2_6_1","first-page":"82","article-title":"Studies on the preservatives especially on the inhibitory activity of polysorbate 80 and lecithin","volume":"91","author":"Ishizeki C.","year":"1973","journal-title":"Eisei Shikensho Hokoku"},{"key":"e_1_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1989.tb00904.x"},{"key":"e_1_2_2_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1998.tb00316.x"},{"key":"e_1_2_2_9_1","first-page":"1056","article-title":"Studies on the antifungal activity of the new imidazole antimycotic lanoconazole in infected sites. Distribution in the skin and in vitro activity in the presence of stratum corneum","volume":"47","author":"Niwano Y.","year":"1997","journal-title":"Arzneimittelforschung\/Drug Research"},{"key":"e_1_2_2_10_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.10.2353"},{"key":"e_1_2_2_11_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.9.1365"},{"key":"e_1_2_2_12_1","first-page":"320","article-title":"A neutralizing medium for evaluating the germicidal potency of the quaternary ammonium salts","volume":"118","author":"Quisno R.","year":"1946","journal-title":"Am. J. Pharm."},{"key":"e_1_2_2_13_1","first-page":"383","volume-title":"Recent trends in the discovery, development and evaluation of antifungal agents","author":"Ritter W.","year":"1987"},{"key":"e_1_2_2_14_1","first-page":"1407","article-title":"A study on effectiveness of treatment and prevention of relapse using topical administration of terbinafine in a guinea pig model for tinea pedis","volume":"47","author":"Uchida K.","year":"1994","journal-title":"Jpn. J. Antibiot."},{"key":"e_1_2_2_15_1","doi-asserted-by":"publisher","DOI":"10.3314\/jjmm.37.199"},{"key":"e_1_2_2_16_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.13.3.423"},{"key":"e_1_2_2_17_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.15.5.706"},{"key":"e_1_2_2_18_1","first-page":"546","article-title":"In vitro studies of a new imidazole antimycotic, bifonazole, in comparison with clotrimazole and miconazole","volume":"33","author":"Yamaguchi H.","year":"1983","journal-title":"Arzneimittelforschung\/Drug Research"}],"container-title":["Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1348-0421.2002.tb02662.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1348-0421.2002.tb02662.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T19:21:42Z","timestamp":1700508102000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1348-0421.2002.tb02662.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["10.1111\/j.1348-0421.2002.tb02662.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1348-0421.2002.tb02662.x","archive":["Portico"],"relation":{},"ISSN":["0385-5600","1348-0421"],"issn-type":[{"value":"0385-5600","type":"print"},{"value":"1348-0421","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}